February 23rd 2025, 7:00pm
By Naoko Sakamoto
Diagnosed with early-stage lung cancer, I chose robot-assisted surgery, navigating pain, fear and the bond with fellow cancer patients through it all.
February 23rd 2025, 3:00pm
By Dr. Laurence Albiges
Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.
February 22nd 2025, 7:00pm
By Jacey Tramutt
The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, regardless of lifestyle choices.
February 22nd 2025, 3:00pm
By Dr. Chandler Park
Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
February 21st 2025, 10:00pm
By Dr. Marwan Fakih
An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.
February 21st 2025, 8:00pm
By Alex Biese
Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.
February 21st 2025, 6:00pm
By Jane Biehl Ph.D.
As a cancer survivor, I describe battling both cancer and infections and the toll it takes on my body.
February 21st 2025, 5:00pm
By Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025, 4:00pm
By Roman Fabbricatore
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
February 21st 2025, 2:00pm
By Ryan Scott
Treatment with tuspetinib in combination with Venclexta and Vidaza in newly diagnosed acute myeloid leukemia showed safety and antileukemic activity.
February 20th 2025, 10:00pm
By Spencer Feldman
Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.
February 20th 2025, 8:05pm
By Ashling Wahner
In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and safe.
February 20th 2025, 6:00pm
By Chester Freeman
My pet provided emotional support and helped me tolerate chemotherapy better, reducing my stress and improving my well-being throughout my cancer journey.
February 20th 2025, 5:00pm
By Dr. Catherine Wu
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
February 20th 2025, 4:00pm
By Dr. Nataliya Uboha
Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.
CPAN Quarterly News Bulletin – June 2025
What Happens When Kids in Families Affected by Cancer Return to School
How to Talk to Your Children About a Cancer Diagnosis
Emphasizing the Need for More Diversity in Cancer Clinical Trials